Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idazoxan in Treating TRD
NCT00294944Phase 3Withdrawn
- Sponsor
- Sheba Medical Center
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of idazoxan in major depressive disorder (MDD), sponsored by Sheba Medical Center. Status: withdrawn.
02
Drugs
idazoxan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00294944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294944.